Trials / Sponsors / Jennifer Amengual
Jennifer Amengual
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Lymphoma, Lymphoma, B-Cell | Phase 2 | 2025-04-14 |
| Withdrawn | Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL Lymphoma, T-Cell, Peripheral | Phase 3 | 2018-09-01 |
| Terminated | ACY-1215 for Relapsed/Refractory Lymphoid Malignancies Lymphoma, Lymphoid Malignancies | Phase 1 / Phase 2 | 2014-04-02 |
| Completed | Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies Lymphoid Malignancies, Multiple Myeloma, Lymphoma | Phase 1 / Phase 2 | 2013-09-09 |